HQLAbrdn Life Sciences Investors
17.35USD+0.96%Mkt Cap: 526.97M USDP/E: 6.21Last update: 2026-05-26
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the…
Industry Peers
Asset Management370.62BSEKP/E 47.1
220.70BSEKP/E 5.5
218.27BSEKP/E 5.4
167.10BUSDP/E 27.1
144.20BUSDP/E 30.3
88.34BUSDP/E 32.2
74.87BUSDP/E 81.7
43.91BUSDP/E 16.1
Indicators:|
Key Statistics
Company
Market Cap526.97M USD
Enterprise Value509.32M USD
Revenue (TTM)1.94M USD
Gross Profit1.94M USD
Net Income (TTM)85.59M USD
Revenue/Share0.0650 USD
Last Price17.35 USD
Fiscal Year EndSep 2025
MR QuarterSep 2025
Employees—
CountryUS
SectorFinancial Services
IndustryAsset Management
ISIN—
Valuation
P/E (Trailing)6.21
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue262.75
P/S269.98
P/B0.99
EPS (TTM)2.79
EPS (Forward)—
52W Range
12.1283% of range18.46
52W High18.46 USD
52W Low12.12 USD
Profitability
Gross Margin100.00%
Oper. Margin-346.83%
EBITDA Margin0.00%
Profit Margin99.08%
ROE16.66%
ROA16.61%
Growth
Revenue Growth-69.90%
Earnings Growth259.40%
Cash Flow & Leverage
Operating CF31.71M USD
CapEx (TTM)—
FCF Margin-112.27%
FCF Yield-0.41%
Net Debt-75.54K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.73
Quick Ratio0.71
Book Value/Sh17.35 USD
Cash/Share0.0030 USD
Dividends
Fwd Div Rate2.040 USD
Trail. Div Rate1.820 USD
Div. Yield11.85%
5Y Avg Yield10.64%
Payout Ratio65.23%
Ex-Div DateMay 21, 2026
Pay DateDec 31, 2018
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.30.41M
Float—
Insiders0.00%
Institutions27.79%
Short Interest
Short Ratio0.2d
Short % Out.0.07%
Shares Short24.09K
Short (prev mo.)39.37K
Technical
SMA 5017.26 (+0.5%)
SMA 20016.38 (+6.0%)
Beta0.74
S&P 52W Chg28.31%
Avg Vol (30d)100.36K
Avg Vol (10d)111.61K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—